Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
International Journal of Hematology|May 2, 2023
Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effectsMichihide Tokuhira, Yuta Kimura, Takayuki Tabayashi, et al.
Clinical Rheumatology|June 23, 2010
Correlation between synovitis detected on enhanced-magnetic resonance imaging and a histological analysis with a patient-oriented outcome measure for Japanese patients with end-stage knee osteoarthritis receiving joint replacement surgeryLizu Liu, Muneaki Ishijima, Ippei Futami, et al.
Medical Oncology (Northwood, London, England)|May 31, 2018
Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitorsTomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, et al.
BMC Cancer|March 12, 2022
Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cellsRyouichi Tsunedomi, Kiyoshi Yoshimura, Yuta Kimura, et al.
Annals of Medicine|April 29, 2022
Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitorsYuriko Nishiyama-Fujita, Tomonori Nakazato, Noriyoshi Iriyama, et al.
Internal Medicine (Tokyo, Japan)|April 2, 2023
Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical PracticeShun Tsuchiya, Tomoiku Takaku, Naoki Watanabe, et al.
Cancer Medicine|February 14, 2025
Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospective Multi-Center Analysis (YPB-003)Hiroto Matsui, Tatsuya Ioka, Toru Kawaoka, et al.
International Journal of Hematology|November 9, 2025
Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study groupNoriyoshi Iriyama, Hitomi Nakayama, Masaru Nakagawa, et al.
International Journal of Hematology|October 2, 2025
Investigation of early mortality in the patients with newly diagnosed multiple myeloma: insights from a real-world cohort using J-CHAEGE-MM databaseMichihide Tokuhira, Hitomi Nakayama, Kohtaro Toyama, et al.
Pageof 8